Vulnerable brain and ventricular assist devices

Stroke

Volumn 47, Issue 11, 2016, Pages 2677-2678

  Roever, Leonardo ^a,c   Resende, Elmiro Santos ^a   Mehra, Mandeep R ^b  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Department of Clinical Research ^*  (Brazil)

Author keywords

Editorials; heart failure; heart ventricles; mortality; stroke; ventricular assist devices

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

ANTICOAGULATION; AORTA; BLOOD CLOTTING; BLOOD PRESSURE REGULATION; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CAROTID ARTERY; CEREBROVASCULAR ACCIDENT; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; DIABETES MELLITUS; EDITORIAL; HUMAN; INCIDENCE; MEDICAL HISTORY; MORTALITY; NEUROLOGICAL COMPLICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; THROMBOPHILIA; VASCULAR BIOLOGY; BRAIN; HEART ASSIST DEVICE; HEART FAILURE; HEART VENTRICLE;

BRAIN; HEART FAILURE; HEART VENTRICLES; HEART-ASSIST DEVICES; HUMANS;

EID: 84988644074     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.116.015036     Document Type: Editorial

References (20)

1. Lala A, Joyce E, Groarke JD, Mehra MR. Challenges in long-Term mechanical circulatory support and biological replacement of the failing heart. Circ J. 2014;78:288-299.
2. Lazar RM, Shapiro PA, Jaski BE, Parides MK, Bourge RC, Watson JT, et al. Neurological events during long-Term mechanical circulatory support for heart failure: the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) experience. Circulation. 2004;109:2423-2427. doi: 10.1161/01.CIR.0000129414.95137.CD.
3. Teuteberg JJ, Slaughter MS, Rogers JG, McGee EC, Pagani FD, Gordon R, et al; ADVANCE Trial Investigators. The HVAD left ventricular assist device: risk factors for neurological events and risk mitigation strategies. JACC Heart Fail. 2015;3:818-828. doi: 10.1016/j.jchf.2015.05.011.
4. Kato TS, Schulze PC, Yang J, Chan E, Shahzad K, Takayama H, et al. Pre-operative and post-operative risk factors associated with neurologic complications in patients with advanced heart failure supported by a left ventricular assist device. J Heart Lung Transplant. 2012;31:1-8. doi: 10.1016/j.healun.2011.08.014.
5. Willey JZ, Demmer RT, Takayama H, Colombo PC, Lazar RM. Cerebrovascular disease in the era of left ventricular assist devices with continuous flow: risk factors, diagnosis, and treatment. J Heart Lung Transplant. 2014;33:878-887. doi: 10.1016/j.healun.2014.05.005.
6. Shah S, Mehra MR, Couper GS, Desai AS. Continuous flow left ventricular assist device related aortic root thrombosis complicated by left main coronary artery occlusion. J Heart Lung Transplant. 2014;33:119-120. doi: 10.1016/j.healun.2013.12.003.
7. Reul JT, Reul GJ, Frazier OH. Carotid-bulb thrombus and continuousflow left ventricular assist devices: a novel observation. J Heart Lung Transplant. 2014;33:107-109. doi: 10.1016/j.healun.2013.10.002.
8. Trachtenberg BH, Cordero-Reyes AM, Aldeiri M, Alvarez P, Bhimaraj A, Ashrith G, et al. Persistent blood stream infection in patients supported with a continuous-flow left ventricular assist device is associated with an increased risk of cerebrovascular accidents. J Card Fail. 2015;21:119-125. doi: 10.1016/j.cardfail.2014.10.019.
9. Lee M, Akashi H, Kato TS, Takayama H, Wu C, Xu K, et al. Vascular inflammation and abnormal aortic histomorphometry in patients after pulsatile-And continuous-flow left ventricular assist device placement. J Heart Lung Transplant. 2016;35:1085-1091. doi: 10.1016/j. healun.2015.12.027.
10. Grosman-Rimon L, Billia F, Fuks A, Jacobs I, A McDonald M, Cherney DZ, et al. New therapy, new challenges: the effects of long-Term continuous flow left ventricular assist device on inflammation. Int J Cardiol. 2016;215:424-430. doi: 10.1016/j.ijcard.2016.04.133.
11. Parikh NS, Cool J, Karas MG, Boehme AK, Kamel H. Stroke risk and mortality in patients with ventricular assist devices. Stroke. 2016;47:2702-2706. doi: 10.1161/STROKEAHA.116.014049.
12. Morgan JA, Brewer RJ, Nemeh HW, Gerlach B, Lanfear DE, Williams CT, et al. Stroke while on long-Term left ventricular assist device support: incidence, outcome, and predictors. ASAIO J. 2014;60:284-289. doi: 10.1097/MAT.0000000000000074.
13. Hsich EM, Naftel DC, Myers SL, Gorodeski EZ, Grady KL, Schmuhl D, et al. Should women receive left ventricular assist device support?: findings from INTERMACS. Circ Heart Fail. 2012;5:234-240. doi: 10.1161/CIRCHEARTFAILURE.111.963272.
14. Bashir J, Legare JF, Freed DH, Cheung A, Rao V, Toma M. Multicentre Canadian experience with the HeartWare ventricular assist device: concerns about adverse neurological outcomes. Can J Cardiol. 2014;30:1662-1667. doi: 10.1016/j.cjca.2014.07.746.
15. Majeed F, Kop WJ, Poston RS, Kallam S, Mehra MR. Prospective, observational study of antiplatelet and coagulation biomarkers as predictors of thromboembolic events after implantation of ventricular assist devices. Nat Clin Pract Cardiovasc Med. 2009;6:147-157. doi: 10.1038/ncpcardio1441.
16. Shah P, Pagani FD. Aortic vasculature changes following support with a continuous-flow left ventricular assist device: The role of pulsatility. J Heart Lung Transplant. 2016;35:421-422. doi: 10.1016/j. healun.2015.12.008.
17. Netuka I, Kvasnička T, Kvasnička J, Hrachovinová I, Ivák P, Mareček F, et al. Evaluation of von Willebrand factor with a fully magnetically levitated centrifugal continuous-flow left ventricular assist device in advanced heart failure. J Heart Lung Transplant. 2016;35:860-867. doi: 10.1016/j.healun.2016.05.019.
18. Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW, Blume ED, et al. Seventh INTERMACS annual report: 15, 000 patients and counting. J Heart Lung Transplant. 2015;34:1495-1504. doi: 10.1016/j. healun.2015.10.003.
19. Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Myers S, Acker MA, et al. Pump thrombosis in the Thoratec HeartMate II device: an update analysis of the INTERMACS Registry. J Heart Lung Transplant. 2015;34:1515-1526. doi: 10.1016/j.healun.2015.10.024.
20. Shah KB, Levenson JL, Mehra MR. Emergent use of mechanical circulatory support devices: ethical dilemmas. Curr Opin Cardiol. 2014;29:281-284. doi: 10.1097/HCO.0000000000000058.